SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium

Rebecca Marlow1, Phyllis Strickland, Ji Shin Lee

  • 1Department of Molecular, Cell and Developmental Biology, University of California, Santa Cruz, California 95064, USA.

Cancer Research
|October 3, 2008
PubMed

Insights

Slits and Robo receptors suppress breast cancer by inhibiting Sdf1/Cxcr4 signaling. Loss of Slits leads to increased Cxcr4, promoting tumor growth and metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Slit and Robo signaling pathways are implicated in tumor suppression.
  • The molecular mechanisms of Slit's tumor-suppressive effects, particularly in breast cancer, remain unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which Slit signaling suppresses breast tumorigenesis.
  • To investigate the relationship between Slit/Robo and the Sdf1/Cxcr4 axis in breast cancer.

Main Methods:

  • Studied Slit and Robo1 expression in murine mammary gland and human breast carcinoma cells.
  • Analyzed Sdf1 and Cxcr4 signaling axis expression.
  • Utilized a xenograft model to assess Slit's effect on tumor growth.

Main Results:

  • Loss of Slits or Robo1 up-regulates Sdf1 and Cxcr4 signaling in mammary epithelium.
  • Observed hyperplastic and desmoplastic changes associated with Slit loss.
  • Found an inverse correlation between Slit and Cxcr4 expression in human breast tumors.
  • Slit overexpression suppressed tumor growth and down-regulated CXCR4 in a xenograft model.

Conclusions:

  • Slits act as negative regulators of the Sdf1/Cxcr4 signaling axis.
  • Identified a molecular signature in hyperplastic breast lesions involving prometastatic gene up-regulation.
  • Slit/Robo signaling is a critical suppressor of breast tumorigenesis and metastasis.